CCHE 57357 along with Dana-Farber Cancer Institute, and Boston Children’s Hospital developed a highly customized joint clinical fellowship program, initially designated in pediatric oncology. Recently the program expanded to include Infectious Diseases in the Immunocompromised and Radiation Oncology; with other tracks soon to follow.
CCHE 57357 developed an international pharmacy residency program that is accredited from the ASHP, with a major emphasis placed on drug-related issues, and practices.
CCHE 57357 in collaboration with Skaggs School of Pharmacy – University of Colorado (CU) established a joint Pharm D program aiming to prepare graduates to be competent, ethical, contemporary and compassionate practicing pharmacists. Additionally, CU faculty deliver live courses in CCHE 57357 including Patient-Centered Communication; Advanced Infectious Diseases; Pharmacogenomics in addition to Cardiovascular Disease Training Symposium.
CCHE 57357 cooperates with this reputable organization in delivering a Healthcare Quality Management and Patient Safety program for organizations that seek capacity building by strengthening quality initiatives.
CCHE 57357 and Arab Academy for Science, Technology, and Maritime Transport collaborate in providing a master’s degree in Business Administration (MBA), with a major focus on healthcare management.
CCHE 57357 is a designated site for Public Health students at HSPH to do the practicum for the graduation projects.
CCHE 57357 is listed as an international site for the Ex Pharm D students. So far two Experiential Learning Program, which is part of Maryland University PharmD. program; students come during their senior years for their elective rotations at CCHE 57357.
CCHE 57357 is one of the authorized training sites; two POEM workshops addressing Minimal Residual Disease and Acute Lymphoblastic Leukemia were held in CCHE 57357
CCHE 57357 is currently part of St. Jude Global Alliance.
CCHE 57357 and TCH/BCM work in collaboration to transfer medical knowledge to most deprived communities in sub-Saharan African countries. Also, there are joint research projects in gene-therapy, and cell-therapy of pediatric malignancies.
What We Offer
Learn More About Our Unique Programs and Training Opportunities